Novo Nordisk shows commercial recovery with accelerating patient additions in obesity and diabetes. Read why NVO stock is a hold. - Novo Nordisk shows commercial recovery with accelerating patient additions in obesity and diabetes, and strong initial traction for the Wegovy…
McDonald’s is testing GLP-1 menu ideas as the fast-food giant considers adding more protein-focused meals for customers taking weight-loss medications such as Ozempic, Wegovy, and Zepbound. The potential changes could bring grilled chicken, protein bowls, and other alternatives to a…
By Dr Catherine Conlon 5th November 2026 0 It seems that Irish policy makers would prefer to celebrate the opening of twenty-five more food outlets over five years than acknowledge the reality of the impact of a vast multinational organisation on both the…
Kelowna, British Columbia – November 4, 2026 – TheNewswire - Lexaria Bioscience Corp. LEXX (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, announces that it has entered into an Agreement with an unnamed pharmaceutical company (“PharmCo”) to investigate Lexaria’s DehydraTECH technology with…
Brazil has 16.6 million adults aged 20–79 living with diabetes and ranks sixth globally in terms of the number of adults living with diabetes. Reflecting the significant treatment need in the country, the semaglutide market for diabetes is estimated at approximately USD…
Novo Nordisk raised its 2026 outlook for the second time in three months, and the stock jumped about 5% on Wednesday. CEO Mike Doustdar wouldn't forecast 2027, but he listed three things helping next year's sales and three hurting them. A Medicare program…
New Delhi, Nov 5 (PTI) Drug firm Alembic Pharmaceuticals Ltd has received final approval from the US health regulator for its Abbreviated New Drug Application (ANDA) for Olopatadine Hydrochloride Ophthalmic Solution USP. The approved product is therapeutically equivalent to the reference…
Dr. Reddy's gets Brazil OK for diabetes drug InvestyWise Dr. Reddy’s receives Brazil marketing authorization for generic semaglutide injection Dr. Reddy’s Laboratories announced that Brazil’s National Health Surveillance Agency (ANVISA) has granted marketing authorization for its generic semaglutide injection. This…
BioSpace Amylyx Pharmaceuticals to Host Investor Event at ObesityWeek® 2026 Featuring Leading PBH Experts CAMBRIDGE, Mass.--(BUSINESS WIRE)--$AMLX--Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) (“Amylyx” or the “Company”) today announced that it will host an investor event at the ObesityWeek® Annual…
By the end of Q3, the Denmark-based pharmaceutical company said it had rolled out the pill form of its weight-loss drug in eight countries. The finance leadership change comes as the company grows the market for its blockbuster Wegovy GLP-1 by…
The GLP-1 market as a business: Wegovy, Zepbound and the new pills, Novo and Lilly's sales race, prices, insurance coverage, compounders and telehealth sellers.
An article joins this feed when it matches these terms. Each one is also a search of its own.